Chairman and CEO of Biostar Pharmaceuticals Adopts 10b5-1 Share Repurchase Plan to Purchase up to 200K Shares

Biostar Pharmaceuticals, Inc.

today announced that, following the Board's approval, the Company's Chief Executive Officer and Chairman of the Board, Ronghua Wang, has adopted a stock trading plan in accordance with the guidelines specified by Exchange Rules 10b5-1 and 10b-18 and other legal SEC legal requirements under the Exchange Act. The Plan is effective as of June 1, 2011 and is valid through November 11, 2011. Under this plan, Mr. Wang may purchase up to 200,000 shares of the Company's common stock, subject to certain conditions.